CLYDESDALE PHARMA LTD
Significant control: Sikdar Consulting Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Clydesdale Pharma Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Clydesdale Pharma Ltd sell?
Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
CLYDESDALE PHARMA LTD is an active private limited company (company number 12009053) incorporated on 21 May 2019, registered in Tadley. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 31 March 2025, showing net assets of £1.63m and cash of £3,235, with 9 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 78% on the prior period (£916k).
By net assets it sits in the top quarter of 1,797 comparable companies in the UK (median £3,718, upper quartile £148k).
Ownership and control
- Sikdar Consulting Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
- Dr Soumick Sikdar
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
- Dr Soumick Sikdar
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 21 May 20197 yrs ago
- Next accounts due
- 31 December 2026in 66 days
- Confirmation statement due
- 4 June 2027in 221 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 46460
- Wholesale of pharmaceutical goods
- SIC 70229
- Management consultancy activities other than financial management
- Accounts type
- Unaudited Abridged
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | £1.63m | £3,235 | £531k | £625k | — | — | 9 |
| 31 March 2024 | £916k | £1,601 | £548k | £587k | — | — | 5 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets above zeroNet assets £1,632,223 at 31 March 2025
- Net assets up 10% or more on the prior period+78.3% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 2.47
- Incorporated five or more years agoIncorporated 21 May 2019
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Confirmation statement duein 221 days
- Next accounts duein 66 days
- Accounts period endNet assets £1.63m · abridged accounts
- Accounts period endNet assets £916k · abridged accounts
- Incorporated
Similar companies in Reading
- LIVRAH LTDMaidenhead · inc. Apr 2019
- AEVITAS BIOPHARMA CO LTDSlough · inc. Jul 2019
- IHEALTH PHARMA LIMITEDMarlow · inc. Mar 2019
- PRO ORBIT LIMITEDBracknell · inc. Jan 2019
- KARO HEALTHCARE UK LTDMaidenhead · inc. Jan 2019
- ELIXIA HOLDINGS LIMITEDHook · inc. Sept 2019
All companies incorporated on 21 May 2019 · in May 2019.
Reminders for CLYDESDALE PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.